{"id":"NCT02209519","sponsor":"University of Alabama at Birmingham","briefTitle":"Randomized Controlled Trial of Treatment of Male Partners of Women With BV","officialTitle":"Randomized Controlled Trial of Treatment of Male Partners of Women With BV","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-02","primaryCompletion":"2019-03","completion":"2019-03","firstPosted":"2014-08-06","resultsPosted":"2020-04-27","lastUpdate":"2020-04-27"},"enrollment":214,"design":{"allocation":"RANDOMIZED","model":"SINGLE_GROUP","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Recurrent Bacterial Vaginosis"],"interventions":[{"type":"DRUG","name":"Metronidazole (male partner)","otherNames":[]},{"type":"OTHER","name":"Placeob (male partner)","otherNames":[]}],"arms":[{"label":"Metronidazole","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"Male partners of womoen with recurrent bacteria vaginosis are randomized to treatment with metronidazole or placebo to compare the rates of recurrent BV in the women","primaryOutcome":{"measure":"Number of Female Partners Whose Male Partners Received Metronidazole Versus Females Whose Male Partners Did Not Receive Metrodiazole With Recurrence of BV in the Female","timeFrame":"16 weeks post start of receipt of study drug","effectByArm":[{"arm":"Metronidazole","deltaMin":87,"sd":null},{"arm":"Placebo","deltaMin":86,"sd":null}],"pValues":[]},"eligibility":{"minAge":"19 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["33383580"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":107},"commonTop":["Infections and infestations","gastrointestinal","nervous","respiratory","Injury"]}}